{"id":"https://openalex.org/W2014898487","doi":"https://doi.org/10.1081/jlc-100107724","title":"HPLC-UV METHOD DEVELOPMENT AND IMPURITY PROFILING OF THE MARINE ANTICANCER AGENT APLIDINE IN RAW DRUG SUBSTANCE AND PHARMACEUTICAL DOSAGE FORM","display_name":"HPLC-UV METHOD DEVELOPMENT AND IMPURITY PROFILING OF THE MARINE ANTICANCER AGENT APLIDINE IN RAW DRUG SUBSTANCE AND PHARMACEUTICAL DOSAGE FORM","publication_year":2001,"publication_date":"2001-12-31","ids":{"openalex":"https://openalex.org/W2014898487","doi":"https://doi.org/10.1081/jlc-100107724","mag":"2014898487"},"language":"en","primary_location":{"id":"doi:10.1081/jlc-100107724","doi":"https://doi.org/10.1081/jlc-100107724","is_oa":false,"landing_page_url":"https://doi.org/10.1081/jlc-100107724","pdf_url":null,"source":{"id":"https://openalex.org/S123147032","display_name":"Journal of Liquid Chromatography & Related Technologies","issn_l":"1082-6076","issn":["1082-6076","1520-572X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Liquid Chromatography & Related Technologies","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085958205","display_name":"Bastiaan Nuijen","orcid":"https://orcid.org/0000-0002-8652-3560","observed_orcids":["https://orcid.org/0000-0002-8652-3560"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"B. Nuijen","raw_affiliation_strings":["a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025898209","display_name":"I. M. Rodrigues-Campos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. M. Rodrigues-Campos","raw_affiliation_strings":["b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041155796","display_name":"C. P. Noain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"C. P. Noain","raw_affiliation_strings":["b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035072011","display_name":"Pablo Floriano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"P. Floriano","raw_affiliation_strings":["b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111696201","display_name":"Consuelo Manada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"C. Manada","raw_affiliation_strings":["b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b  Pharma Mar SA , 28760, Tres Cantos,  Madrid ,  Spain","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"Pharma Mar SA , 28760, Tres Cantos, Madrid , Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109446840","display_name":"Marjan Bouma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Bouma","raw_affiliation_strings":["a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112448190","display_name":"Jantien J. Kettenes-van den Bosch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. J. Kettenes-van den Bosch","raw_affiliation_strings":["c   Department of Biomolecular Mass Spectrometry , Utrecht University ,  Utrecht ,  3584 CA ,  The Netherlands","Department of Biomolecular Mass Spectrometry , Utrecht University , Utrecht , 3584 CA , The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c   Department of Biomolecular Mass Spectrometry , Utrecht University ,  Utrecht ,  3584 CA ,  The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Department of Biomolecular Mass Spectrometry , Utrecht University , Utrecht , 3584 CA , The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077533173","display_name":"A. Bult","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A. Bult","raw_affiliation_strings":["c   Department of Biomolecular Mass Spectrometry , Utrecht University ,  Utrecht ,  3584 CA ,  The Netherlands","Department of Biomolecular Mass Spectrometry , Utrecht University , Utrecht , 3584 CA , The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c   Department of Biomolecular Mass Spectrometry , Utrecht University ,  Utrecht ,  3584 CA ,  The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Department of Biomolecular Mass Spectrometry , Utrecht University , Utrecht , 3584 CA , The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. H. Beijnen","raw_affiliation_strings":["a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a   Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute ,  Amsterdam ,  1066 EC ,  The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology , Slotervaart Hospital, The Netherlands Cancer Institute , Amsterdam , 1066 EC , The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5085958205"],"corresponding_institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"],"apc_list":null,"apc_paid":null,"fwci":0.7589,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.68489714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"24","issue":"20","first_page":"3119","last_page":"3139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/impurity-profiling","display_name":"impurity profiling","score":0.7639999985694885},{"id":"https://openalex.org/keywords/purity-determination","display_name":"purity determination","score":0.5889999866485596},{"id":"https://openalex.org/keywords/cis-trans-isomerism","display_name":"cis-trans isomerism","score":0.7770000100135803},{"id":"https://openalex.org/keywords/rotamers","display_name":"rotamers","score":0.746999979019165},{"id":"https://openalex.org/keywords/dosage-forms","display_name":"pharmaceutical dosage forms","score":0.7099999785423279},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8883162140846252},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8426938652992249},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.7156239151954651},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6818149089813232},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.5986800193786621},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.5380316376686096},{"id":"https://openalex.org/C206139338","wikidata":"https://www.wikidata.org/wiki/Q192355","display_name":"Raw material","level":2,"score":0.5356264710426331},{"id":"https://openalex.org/C23531484","wikidata":"https://www.wikidata.org/wiki/Q3196863","display_name":"Calibration curve","level":3,"score":0.5203956365585327},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.5136165022850037},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.4959774911403656},{"id":"https://openalex.org/C3017686574","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"Gradient elution","level":3,"score":0.47309044003486633},{"id":"https://openalex.org/C2779535233","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Pharmaceutical drug","level":3,"score":0.46784695982933044},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.46508070826530457},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42997485399246216},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.4210802912712097},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.3392510414123535},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12552332878112793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.06574186682701111},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1081/jlc-100107724","doi":"https://doi.org/10.1081/jlc-100107724","is_oa":false,"landing_page_url":"https://doi.org/10.1081/jlc-100107724","pdf_url":null,"source":{"id":"https://openalex.org/S123147032","display_name":"Journal of Liquid Chromatography & Related Technologies","issn_l":"1082-6076","issn":["1082-6076","1520-572X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Liquid Chromatography & Related Technologies","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2021460981","https://openalex.org/W2028173172","https://openalex.org/W2104802653","https://openalex.org/W2321597617","https://openalex.org/W2344269734"],"related_works":["https://openalex.org/W3184222729","https://openalex.org/W6930122969","https://openalex.org/W3204181472","https://openalex.org/W3088241646","https://openalex.org/W4281770793","https://openalex.org/W2381039280","https://openalex.org/W2950548112","https://openalex.org/W7219394793","https://openalex.org/W2379315921","https://openalex.org/W3206745917"],"abstract_inverted_index":{"The":[0],"development":[1],"and":[2,20,29,55,85,91,123,141],"validation":[3],"of":[4,23,45,48,72,75,98,107],"a":[5,43],"reversed-phase":[6],"high":[7],"performance":[8],"liquid":[9,126],"chromatographic":[10,134],"(RP-HPLC)":[11],"method":[12],"with":[13,77],"ultra-violet":[14],"(UV)":[15],"detection":[16],"for":[17],"the":[18,38,49,53,59,70],"quantification":[19],"purity":[21],"determination":[22],"aplidine":[24,39,76,108,137],"in":[25,58,69,133],"raw":[26,109,138],"drug":[27,110,139],"substance":[28,111,140],"pharmaceutical":[30,143],"dosage":[31,144],"form":[32,145],"is":[33],"described.":[34],"Using":[35],"this":[36],"method,":[37],"rotamers":[40],"present":[41],"as":[42,62,119],"consequence":[44],"cis-trans":[46],"isomerism":[47],"peptide":[50],"bond":[51],"between":[52,136],"proline":[54],"pyruvoyl":[56],"moieties":[57],"molecule,":[60],"elute":[61],"one":[63],"single":[64],"peak.":[65],"Linear":[66],"calibration":[67],"curves":[68],"range":[71],"12.5\u2013300":[73],"\u03bcg/mL":[74],"correlation":[78],"coefficients":[79],">":[80],"0.999":[81],"were":[82,88,117,146],"obtained.":[83],"Within-run":[84],"between-run":[86],"precisions":[87],"\u2264":[89],"2.2%":[90],"accuracy":[92],"was":[93,101],"within":[94],"100.6\u2013101.4%.":[95],"A":[96],"profile":[97,135],"recurrent":[99],"impurities":[100,116],"drawn":[102],"up":[103],"from":[104],"several":[105],"lots":[106],"manufactured":[112],"thus":[113],"far.":[114],"Major":[115],"identified":[118],"didemnin-A,":[120],"acetyldidemnin":[121],"A,":[122],"noraplidine":[124],"using":[125],"chromatography-mass":[127],"spectrometry":[128],"(LC-MS).":[129],"No":[130],"significant":[131],"differences":[132],"its":[142],"found.":[147]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}